Bringing In The Research Dollars! (BiRD)

Gilead Research Scholars: Solid Tumors

Deadline: March 01, 2022 11 pm

Amount: Up to $130,000 USD (inclusive of any indirect costs), to be paid in annual installments of up to $65,000 USD per year for 2 years.


This program is designed to support innovative basic, translational and clinical scientific research related to Oncology Solid Tumors.  This may include, but is not limited to, research focused on:

  • Agnostic approaches to target solid tumors
  • Combinatorial drug strategies/approaches to treatment
  • Resistance mechanism identification/novel approaches to addressing resistance mechanisms
  • Transformative therapeutic modalities/approaches to treatment
  • Patient-specific factors that are predictors of toxicity
  • Genomic polymorphisms and impact treatment response
  • Novel targets and/or biomarkers
  • Novel diagnostic, prevention and treatment strategies
  • Research to improve Quality of Life (QoL) / Patient-Reported Outcomes (PROs) e.g. adverse events, addressing unmet needs for patients
  • Other basic, translational and clinical research that addresses an unmet medical need or a gap in scientific knowledge

More Info:

Add to Calendar